These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 7808485)

  • 21. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
    Deeks SG; Wrin T; Liegler T; Hoh R; Hayden M; Barbour JD; Hellmann NS; Petropoulos CJ; McCune JM; Hellerstein MK; Grant RM
    N Engl J Med; 2001 Feb; 344(7):472-80. PubMed ID: 11172188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.
    Ho DD; Cao Y; Zhu T; Farthing C; Wang N; Gu G; Schooley RT; Daar ES
    N Engl J Med; 1993 Feb; 328(6):380-5. PubMed ID: 8093634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.
    Berry N; Ariyoshi K; Jaffar S; Sabally S; Corrah T; Tedder R; Whittle H
    J Hum Virol; 1998; 1(7):457-68. PubMed ID: 10195267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term non-progressors, survivors and HIV positives.
    Bartnof HS
    BETA; 1995 Jun; ():29-32. PubMed ID: 11362542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections.
    Spira TJ; Jones BM; Nicholson JK; Lal RB; Rowe T; Mawle AC; Lauter CB; Shulman JA; Monson RA
    N Engl J Med; 1993 Feb; 328(6):386-92. PubMed ID: 8093635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    Ho DD; Moudgil T; Alam M
    N Engl J Med; 1989 Dec; 321(24):1621-5. PubMed ID: 2586564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV
    J Infect Dis; 1995 Aug; 172(2):329-39. PubMed ID: 7622874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.
    Bagasra O; Hauptman SP; Lischner HW; Sachs M; Pomerantz RJ
    N Engl J Med; 1992 May; 326(21):1385-91. PubMed ID: 1569974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.
    Stanley SK; Ostrowski MA; Justement JS; Gantt K; Hedayati S; Mannix M; Roche K; Schwartzentruber DJ; Fox CH; Fauci AS
    N Engl J Med; 1996 May; 334(19):1222-30. PubMed ID: 8606717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.
    Imagawa DT; Lee MH; Wolinsky SM; Sano K; Morales F; Kwok S; Sninsky JJ; Nishanian PG; Giorgi J; Fahey JL
    N Engl J Med; 1989 Jun; 320(22):1458-62. PubMed ID: 2716797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.
    Schwartz D; Sharma U; Busch M; Weinhold K; Matthews T; Lieberman J; Birx D; Farzedagen H; Margolick J; Quinn T
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1703-11. PubMed ID: 7888230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.
    Barker E; Bossart KN; Locher CP; Patterson BK; Levy JA
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2953-62. PubMed ID: 9000085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells.
    Busch MP; Eble BE; Khayam-Bashi H; Heilbron D; Murphy EL; Kwok S; Sninsky J; Perkins HA; Vyas GN
    N Engl J Med; 1991 Jul; 325(1):1-5. PubMed ID: 2046708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease.
    Schnittman SM; Greenhouse JJ; Psallidopoulos MC; Baseler M; Salzman NP; Fauci AS; Lane HC
    Ann Intern Med; 1990 Sep; 113(6):438-43. PubMed ID: 1974752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents.
    Wilson CC; Wong JT; Girard DD; Merrill DP; Dynan M; An DD; Kalams SA; Johnson RP; Hirsch MS; D'Aquila RT
    J Infect Dis; 1995 Jul; 172(1):88-96. PubMed ID: 7541065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay.
    Re MC; Furlini G; Gibellini D; Vignoli M; Ramazzotti E; Lolli E; Ranieri S; La Placa M
    J Clin Microbiol; 1994 Sep; 32(9):2152-7. PubMed ID: 7814539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.
    Barker E; Mackewicz CE; Reyes-Terán G; Sato A; Stranford SA; Fujimura SH; Christopherson C; Chang SY; Levy JA
    Blood; 1998 Nov; 92(9):3105-14. PubMed ID: 9787145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.